Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

Medical Care Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.


CSE:PHRX - Post by User

Pharmadrug Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2007)
•••
Post by Fishercat1on Dec 09, 2020 8:12am
122 Views
Post# 32065656

Same Vol or Half We See Double Digits Easy . Level 2

Same Vol or Half We See Double Digits Easy . Level 2 And yup news as no way we get 30 miilion traded without something big coming down the pipe . Take over Trip is my call . L2.
Level II Quotes
Orders
Shares
Bid
Ask
Shares
Orders
18
356,000
0.06
0.06
3,538,000
13
12
601,000
0.055
0.065
1,293,000
13
23
1,704,000
0.05
0.07
1,219,000
8
26
1,348,000
0.045
0.075
498,000
8
30
3,026,000
0.04
0.08
1,015,000
16

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities